RedHill Biopharma (RDHL) EBT Margin Growth (1y) (2013 - 2023)
RedHill Biopharma (RDHL) EBT Margin Growth (1y) (2013 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 342.00 |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | -166.00 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -1,258.00 |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 2,773.00 |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 1,800.00 |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 132.00 |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -16,509.00 |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1,555.00 |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 127,245.00 |
| 10 | RedHill Biopharma | 116.64 Mn | 116.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 444,628.00 |
| Mar 31, 2023 | -31,726.00 |
| Dec 31, 2022 | 4,694.00 |
| Sep 30, 2022 | -15,694.00 |
| Jun 30, 2022 | -6,005.00 |
| Mar 31, 2022 | 3,169.00 |
| Dec 31, 2021 | -72,875.00 |
| Sep 30, 2021 | 1,172.00 |
| Jun 30, 2021 | 5,225.00 |
| Mar 31, 2021 | -149,195.00 |
| Dec 31, 2020 | -65,750.00 |
| Sep 30, 2020 | -71,737.00 |
| Jun 30, 2020 | -84,238.00 |
| Mar 31, 2020 | 106,491.00 |
| Dec 31, 2019 | -16,136.00 |
| Sep 30, 2019 | 33,180.00 |
| Jun 30, 2019 | 54,246.00 |
| Mar 31, 2019 | 8,133.00 |
| Dec 31, 2018 | 17,219.00 |
| Sep 30, 2018 | -53,627.00 |